Pharnext S.C.A. P0X.F Stock
Pharnext S.C.A. Price Chart
Pharnext S.C.A. P0X.F Financial and Trading Overview
| Pharnext S.C.A. stock price | 0.0001 EUR |
| Previous Close | 0.03 EUR |
| Open | 0.03 EUR |
| Bid | 0.04 EUR x N/A |
| Ask | 0.08 EUR x N/A |
| Day's Range | 0.03 - 0.03 EUR |
| 52 Week Range | 0.0001 - 905000 EUR |
| Volume | 1.3K EUR |
| Avg. Volume | 1.34K EUR |
| Market Cap | 3.37K EUR |
| Beta (5Y Monthly) | 1.256479 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -200 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
P0X.F Valuation Measures
| Enterprise Value | 19.69M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.0012382888 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 7.232 |
| Enterprise Value/EBITDA | -0.812 |
Trading Information
Pharnext S.C.A. Stock Price History
| Beta (5Y Monthly) | 1.256479 |
| 52-Week Change | -99.99% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 905000 EUR |
| 52 Week Low | 0.0001 EUR |
| 50-Day Moving Average | 0.96 EUR |
| 200-Day Moving Average | 1604.67 EUR |
P0X.F Share Statistics
| Avg. Volume (3 month) | 1.34K EUR |
| Avg. Daily Volume (10-Days) | 5.3K EUR |
| Shares Outstanding | 87.53K |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | June 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -913.34% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 2.72M EUR |
| Revenue Per Share (ttm) | 0.12 EUR |
| Quarterly Revenue Growth (yoy) | -41.19% |
| Gross Profit (ttm) | 3.56M EUR |
| EBITDA | -24256684 EUR |
| Net Income Avi to Common (ttm) | -36173704 EUR |
| Diluted EPS (ttm) | -1760 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.24M EUR |
| Total Cash Per Share (mrq) | 47.11 EUR |
| Total Debt (mrq) | 20.9M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.438 |
| Book Value Per Share (mrq) | -678.987 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -19856544 EUR |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Pharnext S.C.A.
| Country | Germany |
| State | N/A |
| City | Paris |
| Address | 9 rue des Filles Saint-Thomas |
| ZIP | 75002 |
| Phone | 33 1 41 09 22 30 |
| Website | https://www.pharnext.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 28 |
Pharnext SA, a clinical-stage biopharmaceutical company, engages in the development of therapies for orphan and common neurodegenerative diseases in France. Its products include PXT3003, novel fixed-dose synergistic combination of baclofen, naltrexone, and sorbitol under Phase 3 development for the treatment of Charcot-Marie-Tooth Disease Type 1A; and PXT864, a novel fixed-dose synergistic combination of baclofen and acamprosate under Phase 2a development for the treatment of Alzheimer's Disease and Amyotrophic Lateral Sclerosis. The company was founded in 2007 and is headquartered in Issy-Les-Moulineaux, France.
Q&A For Pharnext S.C.A. Stock
What is a current P0X.F stock price?
Pharnext S.C.A. P0X.F stock price today per share is 0.0001 EUR.
How to purchase Pharnext S.C.A. stock?
You can buy P0X.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pharnext S.C.A.?
The stock symbol or ticker of Pharnext S.C.A. is P0X.F.
Which industry does the Pharnext S.C.A. company belong to?
The Pharnext S.C.A. industry is Biotechnology.
How many shares does Pharnext S.C.A. have in circulation?
The max supply of Pharnext S.C.A. shares is 782.68M.
What is Pharnext S.C.A. Price to Earnings Ratio (PE Ratio)?
Pharnext S.C.A. PE Ratio is now.
What was Pharnext S.C.A. earnings per share over the trailing 12 months (TTM)?
Pharnext S.C.A. EPS is -200 EUR over the trailing 12 months.
Which sector does the Pharnext S.C.A. company belong to?
The Pharnext S.C.A. sector is Healthcare.